Better Imaging. Better Outcomes.
Providing centralized data management, expert review, and global expertise with AI-enabled imaging solutions for today’s clinical trials.
Compliance & Trust
Our platform and services meet the highest compliance standards, ensuring complete regulatory alignment.
FDA 21 CFR Part II
ISO13485
GDPR
HIPPA
SOC 2
Experience Matters
Providing standardized image assessments across a spectrum of therapeutic indications for smarter decisions, quicker studies, and reliable trial endpoints.
Musculoskeletal (MSK)
Abdominal Imaging
Leveraging high-resolution MRI, CT, ultrasound, and AI-driven analysis, we support non-invasive assessment of liver, pancreas, kidneys, and gastrointestinal health and fat fraction analysis for clinical trials. We streamline multi-center studies with centralized data management and advanced image analysis, delivering precise, regulator-ready endpoints that enable accurate monitoring of disease progression, therapy response, and safety, accelerating drug development across hepatology, gastroenterology, and renal medicine.
Early Phase Clinical Trials
AI Terms Everyone Should Know in 2025
In 2025, artificial intelligence isn’t just changing the tech landscape—it’s completely reshaping it. AI terminology has infiltrated our daily vocabulary, yet the difference between those who simply use these AI terms and those who truly understand them often determines who will thrive in this new era. Let’s decode the AI revolution in plain language that empowers rather than confuses.
Obesity / Metabolic
Rare Diseases/Inflammation & Immunology
Oncology
Other
Why Work with IAG?
Worldclass Medical Imaging Expertise in Trials
Comprehensive imaging expertise
We cover all major imaging modalities including MRI, CT, PET, ultrasound, and X-ray. Our standardized protocols ensure consistent, high-quality data from all study sites, delivering reliable, actionable insights that drive clinical trial success.
Global network of radiology and therapeutic experts
Partner with us to access a multi-site global clinical trial imaging network of expert radiology readers, therapeutic specialists and KOLs and scientific expertise. Every image is interpreted with precision to provide clinical insight and ensure reliable trial outcomes.
Collaborative approach with clinical and scientific teams
We collaborate with a strong network of clinical scientists and operational teams, fostering open communication and shared insights. This partnership ensures imaging strategies are fully aligned with your trial objectives, enhancing outcomes and maximizing scientific value at every stage.
Innovative solutions for every trial phase
We support trials at every stage, from early phase to the development of imaging biomarkers and companion diagnostics to approved regulatory assessments in global Phase III studies. With approximately 20 years of experience, we know what regulators require and develop strategies to enable success. Our approach helps speed up timelines while keeping data accurate and compliant.
Dynamika: One Solution for All Imaging Needs
Scalable, secure, and built for trials of all sizes
DYNAMIKA centralizes every step of imaging data management, from capture and de-identification to transfer and review, into one secure, easy-to-use platform. Designed for all studies, it scales effortlessly, safeguards sensitive data with enterprise-grade security, and complies with international privacy and regulatory standards. Seamless integration with eClinical tools, EDCs, and sponsor systems ensures smooth data exchange and streamlined trial operations.
QC and real-time oversight
DYNAMIKA ensures every image meets protocol standards through a mutli-step quality control and resolution process. Data is anonymized and validated as it’s uploaded, reducing errors and delays. Real-time dashboards give Sponsors full visibility into site performance, data quality, and readiness for reads, ensuring reliable results and faster trial progress.
Central review with built-in eCRFs and workflow management.
DYNAMIKA centralizes imaging review with built-in eCRFs and adjudication. Expert readers assess data remotely, entries are validated instantly, and disagreements trigger a transparent adjudication workflow. Every step is documented for compliance, ensuring accurate, regulator-ready imaging endpoints.
AI-enabled workflows
DYNAMIKA integrates AI-enabled imaging intelligence for structured quality control, anonymization, and advanced image analysis. With proven experience in global trials, IAG supports seamless validation, and central review across therapeutic areas. Cloud-based workflows streamline data, enhance reproducibility, and ensure regulatory-ready, AI-enabled trial processes and clinical trial endpoints.
Configurable workflows & role-based access
DYNAMIKA lets you configure workflows and assign role-based permissions, tailoring imaging processes to your trial and team. This ensures efficient operations while maintaining strict oversight and data integrity.
Operational Excellence: Ensuring Reliable, High-Quality Imaging Trials
Experienced project team
IAG’s dedicated project team brings deep operational, technological, and clinical expertise to every trial. Through meticulous planning, proactive communication, and real-time support, they ensure efficient operations, high-quality data, and seamless coordination between sites and sponsors, helping trials stay on track and deliver reliable outcomes.
Dedicated support for sites and investigators
IAG provides hands-on training, real-time troubleshooting, and clear guidance to investigators and site staff at every stage. With intuitive tools, standardized protocols, and 24/7 expert support, we minimize site burden, ensure high-quality imaging data, and foster strong collaboration, allowing sites to focus on patient care and trial success.
Geographical reach
IAG provides comprehensive support for clinical trials across North America, Europe, Asia-Pacific, Latin America, and beyond. Our established site network enables rapid activation, efficient imaging logistics, and real-time regional support. Our expertise helps sponsors run multi-center, multi-country studies smoothly, ensuring consistent, high-quality imaging and faster global enrollment.
Minimizing site burden
IAG’s intuitive workflows, streamlined platforms, and comprehensive training reduce administrative workload and simplify imaging processes. Automated data capture, clear communication, and proactive support help sites focus on patient care while delivering high-quality, on-time imaging data, making trial participation efficient and stress-free.
Let’s Speak!
Speak with a member of our team
Publicly announced partnerships
For nearly 20 years, we’ve helped sponsors accelerate drug development by combining scientific expertise, operational excellence, and innovative technology.
What we can do for You:
Talk to IAG Team
If you are planning a clinical trial which will use imaging to assess safety and efficacy of your new drug candidate, share your challanges with our team.
More Questions?
How experienced is IAG in managing imaging for clinical trials?
IAG combines its proprietary DYNAMIKA platform with in-house radiology and therapeutic expertise to deliver tailored imaging strategies across oncology, immunology, neurology, rare diseases, and more. With real-time quality control, AI-powered endpoints, and a quality-certified global network, IAG helps reduce sample sizes, accelerate timelines, and provide reliable, regulator-ready imaging data.
How many trials has IAG successfully supported?
Since 2007, IAG has supported over 700 global clinical trials across all phases and therapeutic areas. Our expertise and advanced imaging solutions help optimize trial workflows, accelerate timelines, and support regulatory success for novel therapies.
How does IAG use AI to improve imaging analysis and trial endpoints?
IAG integrates AI and advanced analytics via its DYNAMIKA platform to transform image review and endpoint assessment. Key capabilities include:
– AI-Powered Endpoints: Accelerate detection of treatment effects and improve trial reliability.
– Automated, Quantitative Analysis: Extract imaging biomarkers to optimize patient selection and forecast outcomes.
– Radiomics & Pathomics: Combine image and pathology data for predictive, personalized insights.
– Early, Sensitive Detection: Identify subtle disease changes often missed by conventional review.
– Centralized, Blinded Reads: Ensure consistent, reproducible endpoints across multi-site trials.
– Regulatory Compliance: Analytics and review meet standards like 21 CFR Part 11 and ISO 13485.
How does IAG ensure imaging data is secure and compliant?
IAG combines industry-leading certifications with advanced technology safeguards to deliver a secure, compliant, and reliable imaging environment. Key measures include:
– Certifications: SOC II Type I, BSI, ISO 13485, and 21 CFR Part 11 ensure global regulatory compliance and operational security.
– Automated Data Anonymization: Protects patient privacy and meets data protection laws.
– Centralized QC & Audit Trails: Guarantees data integrity, traceability, and consistent quality.
– Secure Cloud Infrastructure: Provides controlled, global access for collaboration while safeguarding sensitive data.
– Ongoing Oversight: Regular audits ensure continuous compliance and improvement.
Where does IAG operate and support clinical trials?
IAG operates worldwide, with offices, teams, and partnerships across the UK, EU, USA, India, China, Australia, Africa, and beyond.
– UK & Europe: Headquarters in London with full operational and project management support.
– USA: Rapidly growing presence supporting AI-driven imaging trials.
– Asia-Pacific: Teams in India and partnerships in China and Australia for seamless regional support.
– Global Site Network: Well-connected sites and radiology readers enable fast setup, efficient data collection, and smooth multi-center execution.
How does IAG’s pricing work, and what value does it provide?
IAG offers flexible, tailored pricing to meet the specific needs of each trial while optimizing budgets without compromising quality. Costs are typically based on:
– Trial Complexity & Phase: Phase I–III or real-world studies
– Sites & Patients: Number of locations and participants
– Imaging Requirements: Modalities, endpoints, and customization
– Service Scope: Site setup, data management, central reads, regulatory support, and system integration